BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33628777)

  • 1. Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs.
    Paszkiewicz-Kozik E; Paziewska A; Kulecka M; Dąbrowska M; Kluska A; Bałabas A; Piątkowska M; Ambrożkiewicz F; Tajer J; Osiadacz W; Romejko-Jarosińska J; Kotarska M; Żeber-Lubecka N; Karczmarski J; Popławska L; Mikula M; Rutkowski P; Walewski J; Ostrowski J
    Biomed Res Int; 2021; 2021():3212878. PubMed ID: 33628777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma.
    Li WX; Dai SX; An SQ; Sun T; Liu J; Wang J; Liu LG; Xun Y; Yang H; Fan LX; Zhang XL; Liao WQ; You H; Tamagnone L; Liu F; Huang JF; Liu D
    Aging (Albany NY); 2021 Apr; 13(8):11833-11859. PubMed ID: 33885377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
    Beheshti A; Stevenson K; Vanderburg C; Ravi D; McDonald JT; Christie AL; Shigemori K; Jester H; Weinstock DM; Evens AM
    Sci Rep; 2019 Nov; 9(1):17161. PubMed ID: 31748664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
    Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
    Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.
    Veryaskina YA; Titov SE; Kovynev IB; Pospelova TI; Fyodorova SS; Shebunyaeva YY; Sumenkova DV; Zhimulev IF
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.
    Hohaus S; Giachelia M; Massini G; Mansueto G; Vannata B; Bozzoli V; Criscuolo M; D'Alò F; Martini M; Larocca LM; Voso MT; Leone G
    Ann Oncol; 2009 Aug; 20(8):1408-13. PubMed ID: 19465421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression levels of miRNA-15a and miRNA-16-1 in circulating tumor cells of patients with diffuse large B-cell lymphoma.
    Tuncer SB; Akdeniz D; Celik B; Kilic S; Sukruoglu O; Avsar M; Ozer L; Ekenel M; Ozel S; Yazici H
    Mol Biol Rep; 2019 Feb; 46(1):975-980. PubMed ID: 30552617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
    Fang C; Zhu DX; Dong HJ; Zhou ZJ; Wang YH; Liu L; Fan L; Miao KR; Liu P; Xu W; Li JY
    Ann Hematol; 2012 Apr; 91(4):553-9. PubMed ID: 21987025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.
    Khare D; Goldschmidt N; Bardugo A; Gur-Wahnon D; Ben-Dov IZ; Avni B
    PLoS One; 2017; 12(11):e0187722. PubMed ID: 29131834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
    Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
    Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
    Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
    Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miRNA content of circulating exosomes in DLBCL patients and in vitro influence of DLBCL-derived exosomes on miRNA expression of healthy B-cells from peripheral blood.
    Caner V; Cetin GO; Hacioglu S; Baris IC; Tepeli E; Turk NS; Bagci G; Yararbas K; Cagliyan G
    Cancer Biomark; 2021; 32(4):519-529. PubMed ID: 34275894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
    Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
    J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).
    Mazan-Mamczarz K; Gartenhaus RB
    Leuk Res; 2013 Nov; 37(11):1420-8. PubMed ID: 24054860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients.
    Song G; Gu L; Li J; Tang Z; Liu H; Chen B; Sun X; He B; Pan Y; Wang S; Cho WC
    Ann Hematol; 2014 Oct; 93(10):1735-43. PubMed ID: 24858372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
    Due H; Brøndum RF; Young KH; Bøgsted M; Dybkær K
    BMC Cancer; 2020 Mar; 20(1):237. PubMed ID: 32192453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas.
    Schmitz R; Renné C; Rosenquist R; Tinguely M; Distler V; Menestrina F; Lestani M; Stankovic T; Austen B; Bräuninger A; Hansmann ML; Küppers R
    Leukemia; 2005 Aug; 19(8):1452-8. PubMed ID: 15973455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
    Székely E; Lindén O; Peterson S; Jerkeman M
    Eur J Haematol; 2016 Oct; 97(4):393-8. PubMed ID: 26872557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.